Department of Medicine, Division of Endocrinology, Metabolism & Clinical Nutrition, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):124-31. doi: 10.1097/MED.0b013e32835ed575.
The athero-protective role of scavenger receptor BI (SR-BI) is primarily attributed to its ability to selectively transfer cholesteryl esters from high-density lipoproteins (HDLs) to the liver during reverse cholesterol transport (RCT). In this review, we highlight recent findings that reveal the impact of SR-BI on lipid levels and cardiovascular disease in humans. Moreover, additional responsibilities of SR-BI in modulating adrenal and platelet function, as well as female fertility in humans, are discussed.
Heterozygote carriers of P297S, S112F and T175A-mutant SR-BI receptors were identified in patients with high HDL-cholesterol levels. HDL from P297S-SR-BI carriers was unable to mediate macrophage cholesterol efflux, whereas hepatocytes expressing P297S-SR-BI were unable to mediate the selective uptake of HDL-cholesteryl esters. S112F and T175A-mutant receptors exhibited similar impaired cholesterol transport functions in vitro. Reduced SR-BI function in P297S carriers was also associated with decreased steroidogenesis and altered platelet function. Further, human population studies identified SCARB1 variants associated with female infertility.
Identification of SR-BI variants confirms the key role of this receptor in influencing lipid levels and RCT in humans. A deeper understanding of the contributions of SR-BI to steroidogenesis, platelet function and fertility is required in light of exploration of HDL-raising therapies aimed at reducing cardiovascular risk.
清道夫受体 BI(SR-BI)的抗动脉粥样硬化作用主要归因于其在胆固醇逆向转运(RCT)过程中能够将胆固醇酯从高密度脂蛋白(HDL)选择性地转移到肝脏。在这篇综述中,我们强调了最近的发现,这些发现揭示了 SR-BI 对人类脂质水平和心血管疾病的影响。此外,还讨论了 SR-BI 在调节肾上腺和血小板功能以及人类生育能力方面的额外作用。
在具有高 HDL-胆固醇水平的患者中发现了 P297S、S112F 和 T175A 突变型 SR-BI 受体的杂合子携带者。来自 P297S-SR-BI 携带者的 HDL 无法介导巨噬细胞胆固醇流出,而表达 P297S-SR-BI 的肝细胞无法介导 HDL 胆固醇酯的选择性摄取。体外 S112F 和 T175A 突变型受体表现出相似的胆固醇转运功能受损。P297S 携带者中 SR-BI 功能降低也与类固醇生成减少和血小板功能改变有关。此外,人类群体研究鉴定出与女性不育相关的 SCARB1 变体。
鉴定出 SR-BI 变体证实了该受体在影响人类脂质水平和 RCT 中的关键作用。鉴于正在探索旨在降低心血管风险的升高 HDL 治疗方法,需要更深入地了解 SR-BI 对类固醇生成、血小板功能和生育能力的贡献。